Secretome Therapeutics, based in Dallas, Texas, is developing innovative therapies from neonatal cardiac progenitor cells to treat cardiovascular diseases and other underserved diseases driven by inflammation.
Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.